Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meishiya for CINV Prevention in Solid Tumors
NCT07124195Phase 3Not yet recruiting
- Sponsor
- Xinxiang Medical University First Affiliated Hospital
- Start
- Aug 2025
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of megestrol in chemotherapy-induced nausea and vomiting (CINV), sponsored by Xinxiang Medical University First Affiliated Hospital. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
megestrol
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT07124195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07124195.